Your browser is no longer supported. Please, upgrade your browser.
SILK [NASD]
Silk Road Medical, Inc
Index- P/E- EPS (ttm)-1.51 Insider Own1.50% Shs Outstand34.74M Perf Week-3.96%
Market Cap1.10B Forward P/E- EPS next Y-0.99 Insider Trans-22.63% Shs Float33.99M Perf Month-30.29%
Income-51.90M PEG- EPS next Q-0.36 Inst Own- Short Float5.56% Perf Quarter-49.67%
Sales94.30M P/S11.65 EPS this Y37.10% Inst Trans0.42% Short Ratio5.83 Perf Half Y-39.18%
Book/sh2.54 P/B12.02 EPS next Y25.90% ROA-30.40% Target Price58.67 Perf Year-44.03%
Cash/sh3.41 P/C8.95 EPS next 5Y- ROE-52.80% 52W Range28.97 - 67.49 Perf YTD-28.37%
Dividend- P/FCF- EPS past 5Y- ROI-28.20% 52W High-54.78% Beta-
Dividend %- Quick Ratio6.60 Sales past 5Y- Gross Margin75.20% 52W Low5.35% ATR2.45
Employees281 Current Ratio7.40 Sales Q/Q22.90% Oper. Margin-52.40% RSI (14)30.62 Volatility8.71% 7.47%
OptionableYes Debt/Eq0.55 EPS Q/Q-30.80% Profit Margin-55.00% Rel Volume0.78 Prev Close29.43
ShortableYes LT Debt/Eq0.55 EarningsNov 09 AMC Payout- Avg Volume323.91K Price30.52
Recom1.90 SMA20-17.69% SMA50-25.04% SMA200-38.74% Volume251,857 Change3.70%
Nov-19-21Upgrade Citigroup Sell → Neutral $50
Oct-01-21Downgrade Citigroup Neutral → Sell $50
Oct-01-20Downgrade Citigroup Buy → Neutral $58 → $71
Aug-21-20Initiated Piper Sandler Neutral $54
Jul-09-20Initiated SVB Leerink Outperform $51
May-27-20Initiated Citigroup Buy $50
Aug-20-19Initiated Argus Buy $52
Apr-29-19Initiated Stifel Buy $44
Apr-29-19Initiated JP Morgan Overweight $45
Apr-29-19Initiated BofA/Merrill Neutral $43
Apr-29-19Initiated BMO Capital Markets Outperform
Jan-27-22 10:00AM  
Jan-10-22 01:11PM  
Jan-07-22 05:38PM  
Dec-30-21 04:30PM  
Nov-25-21 09:11AM  
Nov-16-21 12:22PM  
Nov-10-21 04:10PM  
12:31AM  
Nov-09-21 06:45PM  
04:05PM  
Nov-03-21 11:34AM  
Nov-02-21 04:10PM  
03:01PM  
Nov-01-21 11:38AM  
Oct-21-21 04:10PM  
Oct-13-21 11:42AM  
Oct-11-21 03:39PM  
Oct-06-21 11:30AM  
Sep-30-21 11:15AM  
08:50AM  
Sep-29-21 12:00PM  
Sep-15-21 10:50AM  
Sep-01-21 04:10PM  
Aug-18-21 04:15PM  
Jul-30-21 01:32AM  
Jul-29-21 06:35PM  
04:05PM  
Jul-26-21 04:05PM  
Jul-22-21 03:03PM  
Jul-20-21 09:47AM  
Jul-16-21 04:05PM  
Jul-06-21 04:05PM  
Jun-22-21 04:05PM  
May-17-21 01:17PM  
May-12-21 07:16AM  
May-10-21 12:51PM  
May-05-21 03:00AM  
May-04-21 07:20PM  
04:05PM  
02:30PM  
May-03-21 04:05PM  
Apr-20-21 04:05PM  
Apr-15-21 04:05PM  
Apr-02-21 12:11PM  
Mar-25-21 09:42AM  
07:08AM  
Mar-10-21 09:00AM  
06:20AM  
Mar-02-21 10:00AM  
Mar-01-21 06:45PM  
04:35PM  
04:05PM  
02:30PM  
Feb-26-21 12:09PM  
Feb-25-21 04:05PM  
Feb-16-21 04:05PM  
Feb-15-21 09:48PM  
Feb-13-21 03:30PM  
Feb-11-21 01:39PM  
Feb-08-21 07:00PM  
Feb-06-21 11:05PM  
Feb-05-21 03:55AM  
Feb-03-21 12:33PM  
Jan-28-21 11:05PM  
Jan-25-21 11:54PM  
Jan-23-21 11:45PM  
Jan-20-21 11:47PM  
Dec-28-20 08:23AM  
Dec-25-20 07:51AM  
Dec-18-20 01:06PM  
Dec-17-20 04:05PM  
Dec-03-20 04:05PM  
Dec-02-20 12:32PM  
Nov-13-20 08:24AM  
Nov-10-20 07:30PM  
05:35PM  
04:55PM  
04:05PM  
02:30PM  
Nov-06-20 11:49AM  
Nov-04-20 04:05PM  
Nov-03-20 12:31PM  
Oct-20-20 04:05PM  
Oct-12-20 01:00PM  
Oct-01-20 04:05PM  
Sep-21-20 04:05PM  
09:00AM  
Sep-04-20 08:00AM  
Aug-26-20 09:01PM  
Aug-21-20 09:32AM  
Aug-19-20 04:05PM  
Aug-05-20 10:15PM  
08:01PM  
04:05PM  
Jul-29-20 12:33PM  
Jul-23-20 04:35PM  
Jul-22-20 12:01PM  
Jul-09-20 04:05PM  
Jul-05-20 06:41PM  
Jul-03-20 07:18PM  
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Buchanan Lucas W.COO/CFOJan 12Option Exercise1.605,0008,000184,997Jan 14 07:04 PM
Rogers Erica J.President and CEOJan 11Option Exercise1.6010,00016,000142,179Jan 13 06:55 PM
Rogers Erica J.President and CEOJan 11Sale41.8810,000418,787132,179Jan 13 06:55 PM
Rogers Erica J.President and CEODec 13Option Exercise1.6010,00016,000142,179Dec 15 08:39 PM
Rogers Erica J.President and CEODec 13Sale40.9510,000409,530132,179Dec 15 08:39 PM
Rogers Erica J.President and CEONov 30Buy41.302,500103,250132,179Nov 30 07:37 PM
Buchanan Lucas W.COO/CFONov 16Option Exercise4.7310,00047,300189,997Nov 17 07:37 PM
Buchanan Lucas W.COO/CFONov 16Sale50.3210,000503,200179,997Nov 17 07:37 PM
Rogers Erica J.President and CEONov 11Option Exercise1.5515,73824,377142,036Nov 15 06:14 PM
Rogers Erica J.President and CEONov 11Sale50.6218,095915,921129,679Nov 15 06:14 PM
Davis Andrew S.Chief Commercial OfficerNov 01Option Exercise21.094,805101,34373,598Nov 02 07:08 PM
Davis Andrew S.Chief Commercial OfficerNov 01Sale60.964,805292,91270,255Nov 02 07:08 PM
Buchanan Lucas W.COO/CFOOct 27Option Exercise12.1510,000121,500185,808Oct 29 06:06 PM
Buchanan Lucas W.COO/CFOOct 27Sale59.3910,000593,886179,997Oct 29 06:06 PM
Rogers Erica J.President and CEOOct 11Option Exercise1.6011,00017,600143,036Oct 12 08:48 PM
Rogers Erica J.President and CEOOct 11Sale55.7311,000613,014132,036Oct 12 08:48 PM
Davis Andrew S.Chief Commercial OfficerOct 01Option Exercise4.736,32429,91374,028Oct 05 08:24 PM
Davis Andrew S.Chief Commercial OfficerOct 01Sale53.906,324340,87870,255Oct 05 08:24 PM
Buchanan Lucas W.COO/CFOSep 28Option Exercise12.1510,000121,500192,655Sep 29 08:15 PM
Buchanan Lucas W.COO/CFOSep 28Sale54.8610,000548,645182,655Sep 29 08:15 PM
Rogers Erica J.President and CEOSep 13Option Exercise1.6011,00017,600143,036Sep 14 08:23 PM
Rogers Erica J.President and CEOSep 13Sale57.3211,000630,565132,036Sep 14 08:23 PM
Davis Andrew S.Chief Commercial OfficerSep 01Option Exercise4.776,32430,18075,766Sep 03 05:49 PM
Davis Andrew S.Chief Commercial OfficerSep 01Sale59.716,481386,95670,255Sep 03 05:49 PM
Buchanan Lucas W.COO/CFOAug 27Option Exercise12.155,84771,041192,655Aug 31 07:39 PM
Buchanan Lucas W.COO/CFOAug 27Sale54.3810,000543,801182,655Aug 31 07:39 PM
Ruedy RichardEVPClin&Reg.Affairs&QAAug 27Sale55.0015,407847,385117,368Aug 30 08:10 PM
Rogers Erica J.President and CEOAug 11Option Exercise1.6011,00017,600143,036Aug 12 07:32 PM
Rogers Erica J.President and CEOAug 11Sale49.1211,000540,318132,036Aug 12 07:32 PM
Davis Andrew S.Chief Commercial OfficerAug 02Option Exercise4.736,32429,91337,115Aug 03 06:43 PM
Davis Andrew S.Chief Commercial OfficerAug 02Sale50.756,324320,94731,592Aug 03 06:43 PM
Buchanan Lucas W.COO/CFOJul 28Option Exercise25.777,616196,270193,213Jul 29 07:41 PM
Buchanan Lucas W.COO/CFOJul 28Sale44.9110,000449,107186,808Jul 29 07:41 PM
Buchanan Lucas W.COO/CFOJul 27Option Exercise1.603,0004,800189,192Jul 29 07:41 PM
Rogers Erica J.President and CEOJul 12Option Exercise1.6011,00017,600143,036Jul 14 06:54 PM
Rogers Erica J.President and CEOJul 12Sale46.2511,000508,774132,036Jul 14 06:54 PM
Buchanan Lucas W.COO/CFOJul 09Option Exercise1.604,0006,400186,192Jul 12 07:53 PM
Davis Andrew S.Chief Commercial OfficerJul 01Option Exercise4.736,32429,91337,984Jul 06 06:42 PM
Davis Andrew S.Chief Commercial OfficerJul 01Sale48.066,324303,93131,660Jul 06 06:42 PM
Buchanan Lucas W.COO/CFOJun 28Option Exercise20.0010,000200,000192,192Jun 30 05:07 PM
Buchanan Lucas W.COO/CFOJun 28Sale51.6010,000516,021182,192Jun 30 05:07 PM
Rogers Erica J.President and CEOJun 11Option Exercise1.6011,00017,600142,616Jun 14 06:16 PM
Rogers Erica J.President and CEOJun 11Sale47.0211,000517,188131,616Jun 14 06:16 PM
LASERSOHN JACK WDirectorJun 03Sale45.605,427247,4714,769Jun 04 05:53 PM
Davis Andrew S.Chief Commercial OfficerJun 01Option Exercise3.916,32424,72635,907Jun 02 09:26 PM
Davis Andrew S.Chief Commercial OfficerJun 01Sale47.236,324298,66031,240Jun 02 09:26 PM
Buchanan Lucas W.COO/CFOMay 26Option Exercise20.0010,000200,000191,772May 28 07:12 PM
Buchanan Lucas W.COO/CFOMay 26Sale47.5610,000475,572181,772May 28 07:12 PM
Rogers Erica J.President and CEOMay 11Option Exercise1.6011,00017,600142,616May 12 09:38 PM
Rogers Erica J.President and CEOMay 11Sale48.6511,000535,197131,616May 12 09:38 PM
Buchanan Lucas W.COO/CFOMay 05Option Exercise1.605,0008,000181,772May 07 06:39 PM
Davis Andrew S.Chief Commercial OfficerMay 03Option Exercise1.606,32410,11837,564May 04 08:55 PM
Davis Andrew S.Chief Commercial OfficerMay 03Sale62.056,324392,42531,240May 04 08:55 PM
Buchanan Lucas W.COO/CFOApr 28Option Exercise13.1910,000131,917185,445Apr 30 08:28 PM
Buchanan Lucas W.COO/CFOApr 28Sale61.4310,000614,334176,772Apr 30 08:28 PM
Rogers Erica J.President and CEOApr 12Option Exercise1.6011,00017,600142,221Apr 14 08:02 PM
Rogers Erica J.President and CEOApr 12Sale49.7311,000547,067131,616Apr 14 08:02 PM
Davis Andrew S.Chief Commercial OfficerApr 05Sale51.1666033,76731,240Apr 06 08:57 PM
Davis Andrew S.Chief Commercial OfficerApr 01Option Exercise1.606,32410,11838,224Apr 02 09:25 PM
Davis Andrew S.Chief Commercial OfficerApr 01Sale50.866,324321,65431,900Apr 02 09:25 PM
Buchanan Lucas W.COO/CFOMar 29Option Exercise12.1510,000121,500186,347Mar 31 08:00 PM
Buchanan Lucas W.COO/CFOMar 29Sale46.7310,000467,258176,772Mar 31 08:00 PM
Rogers Erica J.President and CEOMar 11Option Exercise1.6011,00017,600142,616Mar 12 06:14 PM
Rogers Erica J.President and CEOMar 11Sale52.9611,000582,518131,616Mar 12 06:14 PM
Davis Andrew S.Chief Commercial OfficerMar 01Option Exercise1.467,47210,90927,274Mar 02 09:32 PM
Davis Andrew S.Chief Commercial OfficerMar 01Sale56.497,472422,12519,802Mar 02 09:32 PM
Buchanan Lucas W.COO/CFOFeb 24Option Exercise10.2810,000102,845171,902Feb 25 06:25 PM
Buchanan Lucas W.COO/CFOFeb 24Sale53.6410,000536,353164,606Feb 25 06:25 PM
Buchanan Lucas W.COO/CFOFeb 17Option Exercise1.6010,00016,000164,606Feb 19 06:16 PM
Rogers Erica J.President and CEOFeb 11Option Exercise1.6011,00017,600122,608Feb 12 07:38 PM
Rogers Erica J.President and CEOFeb 11Sale59.5511,000655,058111,608Feb 12 07:38 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Option Exercise1.467,47210,90927,274Feb 02 06:17 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Sale54.127,472404,39219,802Feb 02 06:17 PM